Virginie A. De Wilde
Route De Lennick
Brussels, BRU, Belgium
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Precision, personalization, and quality of life for patients with lymphoma.
Journal: Current opinion in oncology
Published: August 05, 2025
All you need to know about survivorship in lymphoma in adults and AYA patients.
Journal: Current opinion in oncology
Published: June 13, 2025
Implementing an integrative oncology pathway in a comprehensive cancer center: expert insights and perspectives.
Journal: Current opinion in oncology
Published: May 27, 2025
Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection.
Journal: Leukemia & lymphoma
Published: September 15, 2021
Painful ophthalmoplegia in a patient with a history of marginal zone lymphoma.
Journal: European journal of hybrid imaging
Published: August 05, 2021
Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
Journal: British journal of haematology
Published: July 16, 2021
Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis.
Journal: BMJ case reports
Published: June 24, 2021
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 22, 2021
Moderate forms of COVID-19 among healthcare workers in a Belgian hospital and their immune response.
Moderate forms of COVID-19 among healthcare workers in a Belgian hospital and their immune response.
Journal: Acta clinica Belgica
Published: March 24, 2021
Case Report of an Unusual Tumor in an Adult With a TP53 Germline Mutation.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 25, 2020
Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.
Journal: Frontiers in immunology
Published: July 01, 2020
Last Updated: 09/26/2026